Investing Profile

Krishna Polu

VCInvestor

Executive in Residence at Bioqube Ventures

redtreevc.com/team/San Francisco Bay Area

Your Intro Paths to Krishna Polu

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Krishna is a member of

Stanford University Network

1395 CONNECTIONS

Stanford University Graduate School of Business Network

561 CONNECTIONS

Harvard Medical School Network

64 CONNECTIONS

Amgen Network

42 CONNECTIONS

Abingworth Network

16 CONNECTIONS

Find Krishna Polu on

Current Investing Position

Bioqube Ventures

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Krishna Polu is on these Sector & Stage Rankings

Pharmaceuticals (Seed)ClimateTech/CleanTech (Seed)BioTech (Seed)San Francisco Bay Area Pharmaceuticals (Pre-seed)Health IT (Pre-seed)ClimateTech/CleanTech (Pre-seed)Digital Health (Pre-seed)BioTech (Pre-seed)Health & Hospital Services (Pre-seed)FinTech (Pre-seed)Therapeutics (Pre-seed)Therapeutics (Seed)Health IT (Seed)Digital Health (Seed)FinTech (Seed)Health & Hospital Services (Seed)

Krishna Polu's Investments On Record (1)

Company	StageDateRound Size	Total Raised
Bicara Therapeutics	Series CDec 2023$170M Series BMar 2023$110M	$270M
Co-investors: Ketan Patel (F-Prime Capital Partners), Jake Simson (RA Capital Management)

Krishna Polu's Media (1)

Red Tree Venture Capital Announces Closing of $272 Million Inaugural Fund

www.globenewswire.com

Krishna Polu's Experience

Executive in Residence Bioqube Ventures2023 - Present

Chief Medical Officer AffymaxPresent

Advisor Catalys PacificPresent

Director Board of Directors Frazier Healthcare PartnersPresent

Steering Committee Member, Venture Philanthropy Lupus Research AlliancePresent

Advisor AbingworthPresent

Member of the Investment Committee Lupus VenturesPresent

Interim CEO CEVA SANTE ANIMALEPresent

President and CEO R1 TherapeuticsPresent

Chief Executive Officer Commit Biologics2023 - 2025

Director Board of Directors Sardona Therapeutics2023 - 2023

Director Board of Directors Bicara Therapeutics2022 - 2023

Principal Red Tree Venture Capital2020 - 2023

Member Board Of Directors Frazier Lifesciences Acquisition Corporation2020 - 2022

EVP of R&D and Chief Medical Officer Equillium, Inc.2018 - 2021

Interim CEO Scout Bio2018 - 2018

Entrepreneur In Residence Frazier Healthcare Partners2017 - 2018

Chief Medical Officer Raptor Pharmaceuticals2015 - 2016

Chief Medical Officer CytomX Therapeutics2013 - 2014

Vice President, Clinical Development Affymax2009 - 2013

Executive Director, Clinical Development Amgen2005 - 2009

Krishna Polu's Education

Stanford University Graduate School of Business Certificate Directors Consortium

Harvard Medical School Fellowship in Nephrology

University of Colorado Anschutz Medical Campus Residency in Internal Medicine

The University of Texas Medical School at San Antonio MD

Stanford University BA Human Biology

Investors who invest with Krishna Polu

Scouts & Angels Affiliated With Krishna Polu